Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations

Cell. 2016 Apr 7;165(2):289-302. doi: 10.1016/j.cell.2016.03.020. Epub 2016 Mar 31.

Abstract

Chromosomal translocations encode oncogenic fusion proteins that have been proven to be causally involved in tumorigenesis. Our understanding of whether such genomic alterations also affect non-coding RNAs is limited, and their impact on circular RNAs (circRNAs) has not been explored. Here, we show that well-established cancer-associated chromosomal translocations give rise to fusion circRNAs (f-circRNA) that are produced from transcribed exons of distinct genes affected by the translocations. F-circRNAs contribute to cellular transformation, promote cell viability and resistance upon therapy, and have tumor-promoting properties in in vivo models. Our work expands the current knowledge regarding molecular mechanisms involved in cancer onset and progression, with potential diagnostic and therapeutic implications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Humans
  • Leukemia / genetics
  • Mice
  • Molecular Sequence Data
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Oncogene Proteins, Fusion / genetics
  • RNA / metabolism*
  • RNA, Circular
  • Translocation, Genetic*

Substances

  • MLL-AF9 fusion protein, human
  • Oncogene Proteins, Fusion
  • RNA, Circular
  • Myeloid-Lymphoid Leukemia Protein
  • RNA